Stay updated on Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial

Sign up to get notified when there's something new on the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3 instead of Revision: v3.5.2, indicating a newer release version of the site. This update reflects the refreshed interface/content without altering any study information or user tasks.
    Difference
    0.0%
    Check dated 2026-04-30T16:10:33.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. The page now displays the new revision version.
    Difference
    0.0%
    Check dated 2026-04-16T11:13:11.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Added a new trial site entry for Santiago Metropolitan, Chile (Santiago, 8330074) and updated the locations list. Removed the previous Santiago, Chile entry and added a Plain Language Trial Summary accessible at novctrd.com.
    Difference
    0.3%
    Check dated 2026-04-02T01:37:04.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T18:13:52.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; this appears to be a minor software version update with no visible changes to the study content or layout.
    Difference
    0.0%
    Check dated 2026-03-11T16:45:07.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Site updated to revision v3.4.2; the previous notice about lapse in government funding (v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T09:29:28.000Z thumbnail image

Stay in the know with updates to Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page.